Raymond James & Associates’s First Trust Emerging Markets AlphaDEX Fund FEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.6M Buy
66,739
+2,048
+3% +$47.8K ﹤0.01% 2370
2024
Q2
$1.55M Sell
64,691
-8,150
-11% -$196K ﹤0.01% 2308
2024
Q1
$1.67M Sell
72,841
-5,244
-7% -$119K ﹤0.01% 2275
2023
Q4
$1.73M Buy
78,085
+2,090
+3% +$43.7K ﹤0.01% 2180
2023
Q3
$1.59M Buy
75,995
+16,050
+27% +$350K ﹤0.01% 2155
2023
Q2
$1.27M Sell
59,945
-7,103
-11% -$151K ﹤0.01% 2344
2023
Q1
$1.42M Sell
67,048
-25
-0% -$538 ﹤0.01% 2237
2022
Q4
$1.41M Sell
67,073
-22,234
-25% -$445K ﹤0.01% 2216
2022
Q3
$1.65M Buy
89,307
+8,714
+11% +$183K ﹤0.01% 2090
2022
Q2
$1.72M Sell
80,593
-13,333
-14% -$315K ﹤0.01% 2077
2022
Q1
$2.36M Buy
93,926
+1,064
+1% +$27.4K ﹤0.01% 2008
2021
Q4
$2.42M Buy
92,862
+2,972
+3% +$77.6K ﹤0.01% 2035
2021
Q3
$2.42M Sell
89,890
-9,309
-9% -$256K ﹤0.01% 1970
2021
Q2
$2.77M Sell
99,199
-902
-0.9% -$25.1K ﹤0.01% 1871
2021
Q1
$2.64M Buy
100,101
+6,226
+7% +$165K ﹤0.01% 1828
2020
Q4
$2.37M Sell
93,875
-7,537
-7% -$174K ﹤0.01% 1797
2020
Q3
$2.19M Sell
101,412
-10,394
-9% -$237K ﹤0.01% 1705
2020
Q2
$2.35M Sell
111,806
-51,807
-32% -$1.03M ﹤0.01% 1640
2020
Q1
$2.88M Sell
163,613
-235,893
-59% -$5.55M ﹤0.01% 1363
2019
Q4
$10.6M Buy
399,506
+41,698
+12% +$1.03M 0.01% 872
2019
Q3
$8.42M Sell
357,808
-54,913
-13% -$1.33M 0.01% 942
2019
Q2
$10.4M Buy
412,721
+140,572
+52% +$3.42M 0.02% 836
2019
Q1
$6.81M Buy
272,149
+76,385
+39% +$1.89M 0.01% 1024
2018
Q4
$4.47M Buy
195,764
+56,435
+41% +$1.32M 0.01% 1165
2018
Q3
$3.49M Sell
139,329
-175,736
-56% -$4.45M 0.01% 1448
2018
Q2
$8.15M Buy
315,065
+8,063
+3% +$227K 0.01% 923
2018
Q1
$8.99M Buy
307,002
+211,259
+221% +$6.24M 0.02% 837
2017
Q4
$2.67M Buy
95,743
+15,636
+20% +$427K ﹤0.01% 1503
2017
Q3
$2.19M Buy
80,107
+23,521
+42% +$611K ﹤0.01% 1585
2017
Q2
$1.32M Sell
56,586
-6,475
-10% -$148K ﹤0.01% 1844
2017
Q1
$1.44M Buy
63,061
+52,592
+502% +$1.18M ﹤0.01% 1749
2016
Q4
$213K Sell
10,469
-8,137
-44% -$166K ﹤0.01% 2850
2016
Q3
$386K Sell
18,606
-6,022
-24% -$124K ﹤0.01% 2452
2016
Q2
$473K Buy
+24,628
New +$461K ﹤0.01% 2130
2015
Q4
Sell
-13,309
Closed -$240K 2351
2015
Q3
$240K Sell
13,309
-13,880
-51% -$278K ﹤0.01% 2200
2015
Q2
$624K Sell
27,189
-3,102
-10% -$75.6K ﹤0.01% 1981
2015
Q1
$672K Buy
30,291
+6,082
+25% +$133K ﹤0.01% 1889
2014
Q4
$522K Sell
24,209
-19,350
-44% -$444K ﹤0.01% 1920
2014
Q3
$1.03M Buy
43,559
+10,603
+32% +$272K 0.01% 1476
2014
Q2
$830K Buy
32,956
+4,698
+17% +$115K 0.01% 1602
2014
Q1
$677K Buy
28,258
+1,449
+5% +$34.1K ﹤0.01% 1638
2013
Q4
$666K Buy
26,809
+5,820
+28% +$145K 0.01% 1539
2013
Q3
$510K Sell
20,989
-13,529
-39% -$322K ﹤0.01% 1589
2013
Q2
$795K Buy
+34,518
New +$876K 0.01% 1284

Other funds holding FEM

Raymond James & Associates's FEM Position: Q3 2024 in Review

Raymond James & Associates increased its First Trust Emerging Markets AlphaDEX Fund (FEM) stake by 3.2% in Q3 2024, buying an estimated $47.8K and bringing the position to 66,739 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2370.

Raymond James & Associates first reported a position in FEM in Q2 2013 and has held it in 44 quarters since. The position peaked at $10.6M in Q4 2019. 111 funds tracked by Wall St. Rank hold FEM as of Q3 2024.

  • Raymond James & Associates held 66,739 shares of First Trust Emerging Markets AlphaDEX Fund worth $1.6M as of Q3 2024.
  • Raymond James & Associates bought 2,048 First Trust Emerging Markets AlphaDEX Fund shares in Q3 2024, an estimated $47.8K.
  • First Trust Emerging Markets AlphaDEX Fund made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2370 holding.
  • Raymond James & Associates first reported a position in First Trust Emerging Markets AlphaDEX Fund in Q2 2013 and has held it in 44 quarters since.
  • Raymond James & Associates's First Trust Emerging Markets AlphaDEX Fund position peaked at $10.6M in Q4 2019.
  • 111 funds tracked by Wall St. Rank held First Trust Emerging Markets AlphaDEX Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.